Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Deferred Taxes (2021 - 2025)

Historic Deferred Taxes for Strata Critical Medical (SRTAW) over the last 5 years, with Q3 2025 value amounting to $554000.0.

  • Strata Critical Medical's Deferred Taxes rose 56949.15% to $554000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $453000.0, marking a year-over-year increase of 13861.89%. This contributed to the annual value of -$255000.0 for FY2024, which is 8260.57% up from last year.
  • Per Strata Critical Medical's latest filing, its Deferred Taxes stood at $554000.0 for Q3 2025, which was up 56949.15% from $21000.0 recorded in Q2 2025.
  • Strata Critical Medical's Deferred Taxes' 5-year high stood at $554000.0 during Q3 2025, with a 5-year trough of -$3.6 million in Q3 2021.
  • For the 5-year period, Strata Critical Medical's Deferred Taxes averaged around -$406214.3, with its median value being -$107000.0 (2021).
  • As far as peak fluctuations go, Strata Critical Medical's Deferred Taxes plummeted by 60825.69% in 2022, and later skyrocketed by 56949.15% in 2025.
  • Strata Critical Medical's Deferred Taxes (Quarter) stood at -$109000.0 in 2021, then plummeted by 608.26% to -$772000.0 in 2022, then plummeted by 32.51% to -$1.0 million in 2023, then surged by 89.74% to -$105000.0 in 2024, then surged by 627.62% to $554000.0 in 2025.
  • Its Deferred Taxes stands at $554000.0 for Q3 2025, versus $21000.0 for Q2 2025 and -$17000.0 for Q1 2025.